Related Experiment Video
Updated: Aug 14, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Published on: April 29, 2014
Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca)
1Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Objectives:
To demonstrate that the introduction of the transforming growth factor-beta (TGF-beta) type II receptor (TbetaR-II) decreases tumorigenicity in an aggressive murine renal carcinoma line, Renca. These cells do not express TbetaR-II. Because the presence of TbetaR-II in benign epithelial cells is ubiquitous, the ability to restore tumor suppressor activity in the Renca cell line with its introduction would elucidate the role of TbetaR-II as a tumor suppressor gene.
Methods:
Renca cells were stably transfected with a retrovirus-mediated TbetaR-II expression vector. In vitro sensitivity to growth inhibitory effect of TGF-beta was assessed by the 3H-thymidine incorporation assay. For in vivo testing, xenograft tumors were produced by subcutaneous injection of tumor cells into immunodeficient nude mice. The tumorigenicity of these TbetaR-II transfected cells was tested. Wild-type Renca cells and cells transfected with the control vector were also tested for comparison.
Results:
Expression of TbetaR-II mRNA was evident in Renca cells after transfection with the TbetaR-II construct. In vitro sensitivity to the growth inhibitory effect of TGF-beta was restored. This effect of TGF-beta was reversible with a neutralizing antibody specific for the extracellular domain of TbetaR-II. Xenografts grown from TbetaR-II transfected cells were significantly smaller, weighed less, and developed tumors later than those developed from wild-type Renca cells and those transfected with the control vector.
Conclusions:
We conclude that TbetaR-II is a central mediator of tumorigenicity in Renca cells. As with other tumor suppressor genes, the loss of TbetaR-II expression allows for the development of an aggressive phenotype.
Insights
Restoring transforming growth factor-beta (TGF-beta) type II receptor (TbetaR-II) expression in aggressive Renca cells reduced tumor growth and weight. This demonstrates TbetaR-II’s role as a tumor suppressor gene in renal carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The transforming growth factor-beta (TGF-beta) type II receptor (TbetaR-II) is crucial for TGF-beta signaling.
- TbetaR-II is ubiquitously expressed in benign epithelial cells but often lost in aggressive cancers.
- Renca, a murine renal carcinoma cell line, lacks TbetaR-II expression and exhibits high tumorigenicity.
Purpose of the Study:
- To investigate the role of TbetaR-II as a tumor suppressor gene.
- To determine if restoring TbetaR-II expression in Renca cells can decrease their tumorigenicity.
- To elucidate the mechanism by which TbetaR-II influences renal carcinoma aggressiveness.
Main Methods:
- Stable transfection of Renca cells with a retroviral TbetaR-II expression vector.
- In vitro assessment of TGF-beta sensitivity using a 3H-thymidine incorporation assay.
- In vivo evaluation of tumorigenicity in nude mouse xenograft models, comparing TbetaR-II transfected cells with wild-type and control vector cells.
Main Results:
- TbetaR-II mRNA expression was successfully restored in Renca cells post-transfection.
- Restored TbetaR-II expression re-sensitized cells to TGF-beta's growth inhibitory effects, which was reversible with a neutralizing antibody.
- Xenografts from TbetaR-II transfected cells showed significantly reduced size, weight, and delayed tumor development compared to controls.
Conclusions:
- TbetaR-II acts as a central mediator in controlling tumorigenicity in Renca cells.
- Loss of TbetaR-II expression contributes to the aggressive phenotype of renal carcinoma.
- Restoration of TbetaR-II function holds potential for therapeutic strategies targeting renal cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

